Search research articles
Contact Us
Filters
Showing results (251-260 of 315) with videos related to
Page
of 32
Sort By:
Cancer Treatment Reports
|
September 1, 1977
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination
R C Young, R E Johnson, G P Canellos, et al.
Blood
|
November 1, 1989
Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function
A Pedrazzini, A S Freedman, J Andersen, et al.
Cancer
|
July 1, 1993
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy
M Uematsu, N J Tarbell, B Silver, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 1997
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement
L Hughes-Davies, N J Tarbell, C N Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial
P M Mauch, G P Canellos, L N Shulman, et al.
Leukemia & Lymphoma
|
February 28, 2007
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901
Myron S Czuczman, Pierluigi Porcu, Jeffrey Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome
L N Shulman, B Frisard, J H Antin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study
M R Cooper, K Dear, O R McIntyre, et al.
Gynecologic Oncology
|
July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancer
K J Krag, G P Canellos, C T Griffiths, et al.
Cancer Investigation
|
August 29, 2002
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer
Elizabeth A Johnson, David S Klimstra, James E Herndon, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 315) with videos related to
Sort By:
Page
of 32
Cancer Treatment Reports
|
September 1, 1977
Advanced lymphocytic lymphoma: randomized comparisons of chemotherapy and radiotherapy, alone or in combination
R C Young, R E Johnson, G P Canellos, et al.
Blood
|
November 1, 1989
Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function
A Pedrazzini, A S Freedman, J Andersen, et al.
Cancer
|
July 1, 1993
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy
M Uematsu, N J Tarbell, B Silver, et al.
International Journal of Radiation Oncology, Biology, Physics
|
October 6, 1997
Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement
L Hughes-Davies, N J Tarbell, C N Coleman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1995
Mantle irradiation alone for selected patients with laparotomy-staged IA to IIA Hodgkin's disease: preliminary results of a prospective trial
P M Mauch, G P Canellos, L N Shulman, et al.
Leukemia & Lymphoma
|
February 28, 2007
Results of a phase II study of 506U78 in cutaneous T-cell lymphoma and peripheral T-cell lymphoma: CALGB 59901
Myron S Czuczman, Pierluigi Porcu, Jeffrey Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1993
Primary Ki-1 anaplastic large-cell lymphoma in adults: clinical characteristics and therapeutic outcome
L N Shulman, B Frisard, J H Antin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 1, 1993
A randomized clinical trial comparing melphalan/prednisone with or without interferon alfa-2b in newly diagnosed patients with multiple myeloma: a Cancer and Leukemia Group B study
M R Cooper, K Dear, O R McIntyre, et al.
Gynecologic Oncology
|
July 1, 1989
Predictive factors for long-term survival in patients with advanced ovarian cancer
K J Krag, G P Canellos, C T Griffiths, et al.
Cancer Investigation
|
August 29, 2002
Aberrant p53 staining does not predict cisplatin resistance in locally advanced non-small cell lung cancer
Elizabeth A Johnson, David S Klimstra, James E Herndon, et al.
Page
of 32